Literature DB >> 18719906

Reduced striatal D2 receptor binding in myoclonus-dystonia.

R J Beukers1, J Booij, N Weisscher, F Zijlstra, T A M J van Amelsvoort, M A J Tijssen.   

Abstract

PURPOSE: To study striatal dopamine D(2) receptor availability in DYT11 mutation carriers of the autosomal dominantly inherited disorder myoclonus-dystonia (M-D).
METHODS: Fifteen DYT11 mutation carriers (11 clinically affected) and 15 age- and sex-matched controls were studied using (123)I-IBZM SPECT. Specific striatal binding ratios were calculated using standard templates for striatum and occipital areas.
RESULTS: Multivariate analysis with corrections for ageing and smoking showed significantly lower specific striatal to occipital IBZM uptake ratios (SORs) both in the left and right striatum in clinically affected patients and also in all DYT11 mutation carriers compared to control subjects.
CONCLUSIONS: Our findings are consistent with the theory of reduced dopamine D(2) receptor (D2R) availability in dystonia, although the possibility of increased endogenous dopamine, and consequently, competitive D2R occupancy cannot be ruled out.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18719906     DOI: 10.1007/s00259-008-0924-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  37 in total

1.  The Unified Myoclonus Rating Scale.

Authors:  Steven J Frucht; Sue E Leurgans; Mark Hallett; Stanley Fahn
Journal:  Adv Neurol       Date:  2002

2.  A novel locus for inherited myoclonus-dystonia on 18p11.

Authors:  D A Grimes; F Han; A E Lang; P St George-Hyssop; L Racacho; D E Bulman
Journal:  Neurology       Date:  2002-10-22       Impact factor: 9.910

3.  Elevated putamen D(2) receptor binding potential in major depression with motor retardation: an [11C]raclopride positron emission tomography study.

Authors:  Jeffrey H Meyer; Heather E McNeely; Sandra Sagrati; Anahita Boovariwala; Krystle Martin; N Paul L G Verhoeff; Alan A Wilson; Sylvain Houle
Journal:  Am J Psychiatry       Date:  2006-09       Impact factor: 18.112

Review 4.  Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Authors:  Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-09       Impact factor: 6.200

5.  Myoclonus, motor deficits, alterations in emotional responses and monoamine metabolism in epsilon-sarcoglycan deficient mice.

Authors:  Fumiaki Yokoi; Mai Tu Dang; Jianyong Li; Yuqing Li
Journal:  J Biochem       Date:  2006-06-30       Impact factor: 3.387

6.  Zac1 (Lot1), a potential tumor suppressor gene, and the gene for epsilon-sarcoglycan are maternally imprinted genes: identification by a subtractive screen of novel uniparental fibroblast lines.

Authors:  G Piras; A El Kharroubi; S Kozlov; D Escalante-Alcalde; L Hernandez; N G Copeland; D J Gilbert; N A Jenkins; C L Stewart
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

Review 7.  Pathophysiology of dystonia: a neuronal model.

Authors:  Jerrold L Vitek
Journal:  Mov Disord       Date:  2002       Impact factor: 10.338

Review 8.  The pathophysiological basis of dystonias.

Authors:  Xandra O Breakefield; Anne J Blood; Yuqing Li; Mark Hallett; Phyllis I Hanson; David G Standaert
Journal:  Nat Rev Neurosci       Date:  2008-03       Impact factor: 34.870

9.  Age-related changes in D2 receptor binding with iodine-123-iodobenzofuran SPECT.

Authors:  M Ichise; J R Ballinger; F Tanaka; M Moscovitch; P H St George-Hyslop; D Raphael; M Freedman
Journal:  J Nucl Med       Date:  1998-09       Impact factor: 10.057

10.  The epsilon-sarcoglycan gene (SGCE), mutated in myoclonus-dystonia syndrome, is maternally imprinted.

Authors:  Monika Grabowski; Alexander Zimprich; Bettina Lorenz-Depiereux; Vera Kalscheuer; Friedrich Asmus; Thomas Gasser; Thomas Meitinger; Tim M Strom
Journal:  Eur J Hum Genet       Date:  2003-02       Impact factor: 4.246

View more
  14 in total

Review 1.  Engineering animal models of dystonia.

Authors:  Janneth Oleas; Fumiaki Yokoi; Mark P DeAndrade; Antonio Pisani; Yuqing Li
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

2.  Abnormal nuclear envelopes in the striatum and motor deficits in DYT11 myoclonus-dystonia mouse models.

Authors:  Fumiaki Yokoi; Mai T Dang; Tong Zhou; Yuqing Li
Journal:  Hum Mol Genet       Date:  2011-11-11       Impact factor: 6.150

3.  Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect?

Authors:  Morvarid Karimi; Stephen M Moerlein; Tom O Videen; Robert R Luedtke; Michelle Taylor; Robert H Mach; Joel S Perlmutter
Journal:  Mov Disord       Date:  2010-10-19       Impact factor: 10.338

4.  SGCE isoform characterization and expression in human brain: implications for myoclonus-dystonia pathogenesis?

Authors:  Katja Ritz; Barbera Dc van Schaik; Marja E Jakobs; Antoine H van Kampen; Eleonora Aronica; Marina A Tijssen; Frank Baas
Journal:  Eur J Hum Genet       Date:  2010-12-15       Impact factor: 4.246

5.  Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance.

Authors:  Alessandro Bertolino; Paolo Taurisano; Nicola Marco Pisciotta; Giuseppe Blasi; Leonardo Fazio; Raffaella Romano; Barbara Gelao; Luciana Lo Bianco; Madia Lozupone; Annabella Di Giorgio; Grazia Caforio; Fabio Sambataro; Artor Niccoli-Asabella; Audrey Papp; Gianluca Ursini; Lorenzo Sinibaldi; Teresa Popolizio; Wolfgang Sadee; Giuseppe Rubini
Journal:  PLoS One       Date:  2010-02-22       Impact factor: 3.240

6.  Loss of the dystonia gene Thap1 leads to transcriptional deficits that converge on common pathogenic pathways in dystonic syndromes.

Authors:  Natalie M Frederick; Parth V Shah; Alessandro Didonna; Monica R Langley; Anumantha G Kanthasamy; Puneet Opal
Journal:  Hum Mol Genet       Date:  2019-04-15       Impact factor: 6.150

7.  Deep Brain Stimulation of the Pallidum is Effective and Might Stabilize Striatal D(2) Receptor Binding in Myoclonus-Dystonia.

Authors:  R J Beukers; M F Contarino; J D Speelman; P R Schuurman; J Booij; Marina A J Tijssen
Journal:  Front Neurol       Date:  2012-02-20       Impact factor: 4.003

8.  Alteration of striatal dopaminergic neurotransmission in a mouse model of DYT11 myoclonus-dystonia.

Authors:  Lin Zhang; Fumiaki Yokoi; Dee S Parsons; David G Standaert; Yuqing Li
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

9.  The dopaminergic system in patients with functional dyspepsia analysed by single photon emission computed tomography (SPECT) and an alpha-methyl-para-tyrosine (AMPT) challenge test.

Authors:  Breg Braak; Jan Booij; Tamira K Klooker; Rene M J van den Wijngaard; Guy E E Boeckxstaens
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-12-09       Impact factor: 9.236

10.  Investigating the role of striatal dopamine receptor 2 in motor coordination and balance: Insights into the pathogenesis of DYT1 dystonia.

Authors:  Yuning Liu; Hong Xing; Fumiaki Yokoi; David E Vaillancourt; Yuqing Li
Journal:  Behav Brain Res       Date:  2021-01-18       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.